KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Cash from Operations (2016 - 2026)

Regeneron Pharmaceuticals (REGN) has disclosed Cash from Operations for 18 consecutive years, with 1078900000.0 as the latest value for Q1 2026.

  • For Q1 2026, Cash from Operations rose 3.23% year-over-year to 1078900000.0; the TTM value through Mar 2026 reached 5012700000.0, up 26.8%, while the annual FY2025 figure was 4978900000.0, 12.63% up from the prior year.
  • Cash from Operations hit 1078900000.0 in Q1 2026 for Regeneron Pharmaceuticals, down from 1170700000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 2101700000.0 in Q1 2022 and bottomed at 354000000.0 in Q2 2024.
  • Average Cash from Operations over 5 years is 1181600000.0, with a median of 1144400000.0 recorded in 2025.
  • Year-over-year, Cash from Operations plummeted 81.58% in 2022 and then skyrocketed 223.28% in 2025.
  • Regeneron Pharmaceuticals' Cash from Operations stood at 1719900000.0 in 2022, then tumbled by 36.64% to 1089700000.0 in 2023, then increased by 15.89% to 1262800000.0 in 2024, then decreased by 7.29% to 1170700000.0 in 2025, then dropped by 7.84% to 1078900000.0 in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 1078900000.0, 1170700000.0, and 1618700000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.